Thrombomodulin in the blood of patients with acute cerebral ischaemia

Advances in Clinical and Experimental Medicine

Volumn 15, Issue 2, 2006, Pages 271-277

  Widerkiewicz, Krzysztof ^a   Dzianott Pabijan, Dorota ^b   Masłowska, Barbara ^b   Kotschy, Maria ^c,d  

^a Merck Sharp and Dohme Idea Inc   (Poland)

^b Dr J Biziel Memorial University Hospital   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d NONE   (Poland)

Author keywords

Ischaemic stroke; Soluble thrombomodulin

Indexed keywords

THROMBOMODULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CONTROLLED STUDY; EMBOLISM; ENDOTHELIUM INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TRANSIENT ISCHEMIC ATTACK; VASCULAR ENDOTHELIUM;

EID: 33744812977     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Coolman RW: Review of normal hemostasis. In: Thrombolytic therapy for peripheral vascular disease. Eds.: Comerota AJ, J.B. Lippincott Company, 1995, 266-269.
2. Jaffe AE: Vascular function in hemostasis. In: Hematology. Eds.: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Williams McGraw-Hill, Inc. 1995, 125, 1261-1276.
3. Bajaj MS, Kuppuswamy MN, Manepalli AN, Bajaj SP: Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Thromb Haemost 1999, 82, (3), 1047-1052.
4. Boffa MC, Burke B, Haudenschild CC: Preservation of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem 1987, 35, (11), 1267-1276.
5. Ishii H, Majerus PW: Trombomodulin is present in plasma and urine. J Clin Invest 1985, 76, 2178-2181.
6. Seigneur M, Dufoureq P, Conri C, Constans J, Merci é P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR: Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993, 71, 423-31.
7. Boffa MC, Jackman RW, Peyri N, Boffa JF, George B: Thrombomodulin in the central nervous system. Nouv Rev Fr Hematol 1991, 33(6), 423-429.
8. Wang L, Tran ND, Kittaka M, Fisher MJ, Schreiber SS, Zlotowic BV: Thrombomodulin expression in bovine brain capillaries: Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms. Arteriose Thromb Vasc Biol 1997, 17, (11), 3139-3156.
9. Valen G, Sigurdardottir O, Vaage J: Systemic release of thrombomodulin, but not from the cardioplegic, reperfused heart during open heart surgery. Thromb Res 1996, 83(4), 321-328.
10. Grau GE, De Moerloose P, Bulla O, Lou J, Lei Z, Reber G, Mili N, Ricou B, Morel DR, Suter PM: Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thromb Haemost 1997, 77, (3), 585-590.
11. Ikeda E, Maruyama I, Hosoda Y: Expression of thrombomodulin in patients with spontaneous occlusion of the circle of Willis. Stroke 1993, 24, (5), 657-660.
12. Plow EF, Herre T, Redlitz Miles LA, Hoover-Plow JL: The cell biology of the plasminogen system. FASEB J 1995, 9, 939-945.
13. Blann AD, McCollum CN: Von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis 1999, 10, (6), 375-380.
14. Takano S, Kimura S, Ohdama S, Aoki N: Plasma Thrombomodulin in health and diseases. Blood 1990, 76, (10), 2024-2029.
15. Wiśniewska E, Wodyńska T, Kulwas A, Kotschy M, Nartowicz E, Paczuski R, Michalski A: Thrombomodulin - endothelial thrombin receptor in blood of patients with unstable angina pectoris. Med Sc Mon 2001, 7, 256-259.
16. Kotschy M, Polaszewska-Muszyńska M, Moskal S, Bedowska-Gontarz W, Sikorska Z, Paczuski R: Some vascular endothelial cell markers in diabetes type 2 with proliferative retinopathy. Thromb Haemost 2001, Suppl. Abstract: CD3506.
17. Besbas N, Erbay A, Saatçi Ü, Özdemir S, Bakkaloglu A, Ozen S, Topaloglu R: Thrombomodulin, tissue plasminogen activator and tissue plasminogen activator inhibitor-1 in Henoch-Schönlein purpura. Clin Exp Rheumatol 1998, 16, 95-98.
18. Jansson JH, Boman K, Brännström M, Nilsson K: Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. Eur Heart J 1996, 17, 1503-1505.
19. Fareed J, Messmore HL: Plasma trombomodulin level as a predictor of hemorrhagic (and thrombotic) events in patients on long-term anticoagulant treatment. Circulation 1997, 96, 2765-2768.
20. Shieh SD, Shiang JC, Lin YF, Shiao WY, Wang JY: Circulating angiotensin-converting enzyme, von Willebrand factor antigen and thrombomodulin in exertional heat stroke. Clin Sci Colch 1995, 89, (3), 261-265.
21. Nawroth PP, Häring HU: Thrombomodulin and coronary heart disease (Commentary). Lancet 1999, 353, 1722-1723.
22. Migdalski A, Jawień A, Kotschy M, Knapik-Bieniek A: Selected haemostatic factors in carotid bifurcation plaques of patients undergoing carotid endarterectomy. Eur J Vasc, Endovasc Surg 2004, 27, 172-179.
23. Kotschy M, Knapik-Bieniek A, Migdalski A, Kotschy D, Jawień A: Selected endothelial markers in atherosclerotic plaques and plasma of patients undergoing carotid endarterectomy. Acta Angiol 2004, 10, 173-180.
24. Migdalski A, Kotschy M, Jawień A: tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2005, 30, 41-47.